Methods of producing 7-carbon chemicals via methyl-ester shielded carbon chain elongation

US10196657B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10196657-B2
Application numberUS-201314139072-A
CountryUS
Kind codeB2
Filing dateDec 23, 2013
Priority dateDec 31, 2012
Publication dateFeb 5, 2019
Grant dateFeb 5, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This document describes biochemical pathways for producing pimelic acid, 7-aminoheptanoic acid, 7-hydroxyheptanoic acid, heptamethylenediamine or 1,7-heptanediol by forming two terminal functional groups, comprised of carboxyl, amine or hydroxyl group, in a C7 aliphatic backbone substrate. These pathways, metabolic engineering and cultivation strategies described herein rely on enzymes or homologs accepting methyl ester shielded dicarboxylic acid substrates.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for biosynthesizing pimelic acid or 7-aminoheptanoate, said method comprising: (i) enzymatically converting malonyl-[acp] to pimeloyl-[acp] via (1) contacting malonyl-[acp] with a polypeptide having the activity of a malonyl-[acp] O-methyltransferase classified under EC 2.1.1.197 to form malony-[acp] methyl ester, (2) contacting malonyl-[acp] methyl ester and malony-[acp] with a polypeptide having the activity of a β-ketoacyl-[acp] synthase classified under EC 2.3.1.- to form 3-oxoglutyryl-[acp] methyl ester, (3) contacting 3-oxoglutyryl-[acp] methyl ester with a polypeptide having the activity of a 3-oxoacyl-[acp] reductase classified under EC 1.1.1.100 to form 3-hydroxy-glutaryl-[acp] methyl ester, (4) contacting 3-hydroxy-glutaryl-[acp] methyl ester with a polypeptide having the activity of a 3-hydroxyacyl-[acp] dehydratase classified under EC 4.2.1.59 to form 2,3-dehydroglutaryl-[acp] methyl ester, (5) contacting 2,3-dehydroglutaryl-[acp] methyl ester with a polypeptide having the activity of an enoyl-[acp] reductase classified under EC 1.3.1.10 to form glutaryl-[acp] methyl ester, (6) contacting glutaryl-[acp] methyl ester with a polypeptide having the activity of a β-ketoacyl-[acp] synthase classified under EC 2.3.1.- to form 3-oxopimeloyl-[acp] methyl ester, (7) contacting 3-oxopimeloyl-[acp] methyl ester with a polypeptide having the activity of a 3-oxoacyl-[acp] reductase classified under EC 1.1.1.100 to form 3-hydroxy-pimeloyl-[acp] methyl ester, (8) contacting 3-hydroxy-pimeloyl-[acp] methyl ester with a polypeptide having the activity of a 3-hydroxyacyl-[acp] dehydratase classified under EC 4.2.1.59 to form 2,3-dehydropimeloyl-[acp] methyl ester, (9) contacting 2,3-dehydropimeloyl-[acp] methyl ester with a polypeptide having the activity of an enoyl-[acp] reductase classified under EC 1.3.1.10 to form pimeloyl-[acp] methyl ester, and (10) contacting pimeloyl-[acp] methyl ester with a polypeptide having the activity of a pimelyl-[acp] methyl ester esterase classified under EC 3.1.1.85 to form pimeloyl-[acp]; enzymatically converting malonyl-CoA to pimeloyl-CoA via (1) contacting malonyl-CoA with a polypeptide having the activity of a malonyl-[acp] O-methyltransferase classified under EC 2.1.1.197 to form malonyl-CoA methyl ester, (2) contacting malonyl-CoA methyl ester and acetyl-CoA with a polypeptide having the activity of a β-ketathiolase classified under EC 2.3.1.16 or a β-ketoacyl-[acp] synthase classified under EC 2.3.1.180 to form 3-oxoglutaryl-CoA methyl ester, (3) contacting 3-oxoglutaryl-CoA methyl ester with a polypeptide having the activity of a 3-oxoacyl-[acp] reductase classified under EC 1.1.1.100 or an acetoacetyl-CoA reductase classified under EC 1.1.1.36 to form 3-hydroxy-glutaryl-CoA methyl ester, (4) contacting 3-hydroxy-glutaryl-CoA methyl ester with a polypeptide having the activity of an enoyl-CoA hydratase classified under EC 4.2.1.119 to form 2,3-dehydroglutaryl-CoA methyl ester, (5) contacting 2,3-dehydroglutaryl-CoA methyl ester with a polypeptide having the activity of an enoyl-[acp] reductase classified under EC 1.3.1.10 or a trans-2-enoyl-CoA reductase classified under EC 1.3.1.38, EC 1.3.1.8, or EC 1.3.1.44 to form glutaryl-CoA methyl ester, (6) contacting glutaryl-CoA methyl ester with a polypeptide having the activity of a β-ketoacyl-[acp] synthase classified under EC 2.3.1.- or a β-ketothiolase classified under EC 2.3.1.16 to form 3-oxopimeloyl-CoA methyl ester, (7) contacting 3-oxopimeloyl-CoA methyl ester with a polypeptide having the activity of a 3-oxoacyl-[acp] reductase classified under EC 1.1.1.100 or an acetoacetyl-CoA reductase classified under EC 1.1.1.36 to form 3-hydroxy-pimeloyl-CoA methyl ester, (8) contacting 3-hydroxy-pimeloyl-CoA methyl ester with a polypeptide having the activity of an enoyl-CoA hydratase classified under EC 4.2.1.119 to form 2,3-dehydropimeloyl-CoA methyl ester, (9) contacting 2,3-dehydropimeloyl-CoA methyl ester with a polypeptide having the activity of an enoyl-[acp] reductase classified under EC 1.3.1.10 or a trans-2-enoyl-CoA reductase classified under EC 1.3.1.38, EC 1.3.1.8, or EC 1.3.1.44 to form pimeloyl-CoA methyl ester, and (10) contacting pimeloyl-CoA methyl ester with a polypeptide having the activity of a pimelyl-[acp] methyl ester esterase classified under EC 3.1.1.85 to form pimeloyl-CoA; or enzymatically converting malonyl-CoA to pimeloyl-CoA via (1) contacting malonyl-CoA with a polypeptide having the activity of a malonyl-[acp] O-methyltransferase classified under EC 2.1.1.197 to form malonyl-CoA methyl ester, (2) contacting malonyl-CoA methyl ester and acetyl-CoA with a polypeptide having the activity of a β-ketothiolase classified under EC 2.3.1.16 or a β-ketoacyl-[acp] synthase classified under EC 2.3.1.180 to form 3-oxoglutaryl-CoA methyl ester, (3) contacting 3-oxoglutaryl-CoA methyl ester with a polypeptide having the activity of a 3-hydroxyacyl-CoA dehydrogenase classified under EC 1.1.1.35 or EC 1.1.1.157 to form 3-hydroxy-glutaryl-CoA methyl ester, (4) contacting 3-hydroxy-glutaryl-CoA methyl ester with a polypeptide having the activity of an enoyl-CoA hydratase classified under EC 4.2.1.17 to form 2,3-dehydroglutaryl-CoA methyl ester, (5) contacting 2,3-dehydroglutaryl-CoA methyl ester with a polypeptide having the activity of a trans-2-enoyl-CoA reductase classified under EC 1.3.1.44 to form glutaryl-CoA methyl ester, (6) contacting glutaryl-CoA methyl ester with a polypeptide having the activity of a β-ketoacyl-[acp] synthase classified under EC 2.3.1.- or a β-ketathiolase classified under EC 2.3.1.16 to 3-oxopimeloyl-CoA methyl ester, (7) contacting 3-oxopimeloyl-CoA methyl ester with a polypeptide having the activity of a 3-hydroxyacyl-CoA dehydrogenase classified under EC 1.1.1.35 or EC 1.1.1.157 to form 3-hydroxy-pimeloyl-CoA methyl ester, (8) contacting 3-hydroxy-pimeloyl-CoA methyl ester with a polypeptide having the activity of an enoyl-CoA hydratase classified under EC 4.2.1.17 to form 2,3-dehydropimeloyl-CoA methyl ester, (9) contacting 2,3-dehydropimeloyl-CoA methyl ester with a polypeptide having the activity of a trans-2-enoyl-CoA reductase classified under EC 1.3.1.44 to form pimeloyl-CoA methyl ester, and (10) contacting pimeloyl-CoA methyl ester with a polypeptide having the activity of a pimelyl-[acp] methyl ester esterase classified under EC 3.1.1.85 to form pimeloyl-CoA; and (ii) (a) enzymatically converting pimeloyl-CoA or pimeloyl-[acp] to pimelic acid via (1) contacting pimeloyl-CoA or pimeloyl-[acp] with a polypeptide having the activity of a thioesterase classified under EC 3.1.2.- to form pimelic acid, (2) contacting pimeloyl-CoA with a polypeptide having the activity of a glutaconate CoA-transferase classified under EC 2.8.3.12 or a reversible succinate-CoA ligase classified under EC 6.2.1.5 to form pimelic acid, or (3) contacting pimeloyl-CoA with a polypeptide having the activity of an acetylating aldehyde dehydrogenase classified under EC 1.2.1.10 to form pimelate semialdehyde and contacting pimelate semialdehyde with a polypeptide having the activity of a 7-oxoheptanoate dehydrogenase classified under EC 1.2.1.-, a 6-oxohexanoate dehydrogenase classified under EC 1.2.1.-, or an aldehyde dehydrogenase classified under EC 1.2.1.3 to form pimelic acid; or (b) enzymatically converting pimeloyl-CoA or pimeloyl-[acp] to 7-aminoheptanoate via (1) contacting pimeloyl-CoA with a polypeptide having the activity of an acetylating aldehyde dehydrogenase classified under EC 1.2.1.10 to form pimelate semialdehyde and contacting pimelate semialdehyde with a polypeptide having the activity of a ω-transaminase classified under EC 2.6.1.- to form 7-aminoheptanoate, or (2) contacting any one of pimelic acid formed in (ii)(a) with a polypeptide having the activity of a carboxylate reductase classified under EC 1.2.99.6 to form pimelate semialdehyde and contacting pimelate semi

Assignees

Inventors

Classifications

  • Methyltransferases (general) (2.1.1.) · CPC title

  • Lyases (4.) · CPC title

  • C12P13/001Primary

    Amines; Imines · CPC title

  • Polycarboxylic acids · CPC title

  • acting on CH-OH groups as donors (1.1) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10196657B2 cover?
This document describes biochemical pathways for producing pimelic acid, 7-aminoheptanoic acid, 7-hydroxyheptanoic acid, heptamethylenediamine or 1,7-heptanediol by forming two terminal functional groups, comprised of carboxyl, amine or hydroxyl group, in a C7 aliphatic backbone substrate. These pathways, metabolic engineering and cultivation strategies described herein rely on enzymes or homol…
Who is the assignee on this patent?
Invista North America Sarl, Invista North America Sarl
What technology area does this patent fall under?
Primary CPC classification C12P13/001. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).